Frontlight ResearchEarly access
Not yet taking people in NorwayPhase 4
Zoledronic acid compared with placebo for hip osteoarthritis
Tests zoledronic acid against placebo in adults with hip osteoarthritis.
Key facts
- Who runs it
- Martina Hansens Hospital AS
- Where
- Gjettum, NorwaySee the site
- Trial code
- Registry title
- A randomized placebo controlled trial testing the effect of Zoledronic Acid on Hip osteoarthritis
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 70 people, planned
- Started
- 28 Apr 2025
- Planned end
- 30 Jun 2026
- Type of study
- Interventional
- Record updated
- 15 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with osteoarthritis of the hip. It tests Zoledronic Acid against a placebo (a dummy treatment).
- Age
- 18 Years and older
- Sex
- All sexes
- Disease stage
- Osteoarthritis of the hip
Main reasons for not taking part
- Healthy volunteers cannot join
Where in Norway
- Martina Hansens Hospital ASGjettum, NorwayNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Plain-language title
- Zoledronic acid compared with placebo for hip osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 15 May 2025